BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/2/2026 8:38:25 AM | Browse: 1 | Download: 0
Publication Name World Journal of Clinical Oncology
Manuscript ID 121469
DOI 10.5306/wjco.121469
Country United States
Category Public, Environmental & Occupational Health
Manuscript Type Minireviews
Article Title From residue to cancer risk: How thirdhand smoke drives cancer hallmarks
Manuscript Source Unsolicited Manuscript
All Author List Jian-Hua Mao and Hang Chang
Funding Agency and Grant Number
Funding Agency Grant Number
the University of California Tobacco Related Disease Research Program (UC TRDRP) No. T32PT6221
Corresponding Author Hang Chang, PhD, Principal Investigator, Division of Biological Systems and Engineering, Berkeley Biomedical Data Science Center, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94720, United States. hchang@lbl.gov
Key Words Environmental carcinogenesis; Thirdhand smoke; Cancer hallmarks; Nicotine-derived tobacco-specific nitrosamines; Polycyclic aromatic hydrocarbons; Heavy metals; Risk assessment
Core Tip Thirdhand smoke (THS) represents a persistent and underrecognized environmental carcinogen whose complex chemical mixture drives cancer-relevant biological processes beyond the window of active smoking. By integrating THS-induced molecular and cellular perturbations, such as DNA damage, epigenetic reprogramming, oxidative stress, and chronic inflammation, within the framework of the hallmarks of cancer, a systems-level paradigm for carcinogenic risk assessment emerges. This approach moves beyond traditional single-endpoint toxicology to capture the cumulative, multi-pathway impact of chronic low-dose exposures. Applying this framework to THS reveals how residual tobacco toxicants synergistically disrupt multiple cancer hallmarks, providing a mechanistically grounded basis for evaluating long-term cancer risk and informing environmental health policy.
Citation Mao JH, Chang H. From residue to cancer risk: how thirdhand smoke drives cancer hallmarks. World J Clin Oncol 2026; In press
Received
2026-03-25 00:43
Peer-Review Started
2026-03-25 00:45
First Decision by Editorial Office Director
2026-04-04 02:35
Return for Revision
2026-04-04 02:35
Revised
2026-04-13 17:03
Publication Fee Transferred
2026-04-17 18:20
Second Decision by Editor
2026-06-02 02:42
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-02 08:38
Articles in Press
2026-06-02 08:38
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2218-4333 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com